Cited by 102Genomic variations and chromosomal abnormalitiesGenetic Syndromes and ImprintingGenetics and Neurodevelopmental Disorders

Clinical and genetic aspects of the 15q11.2 BP1–BP2 microdeletion disorder

Open access
Butler, M. G.·2017·Journal of Intellectual Disability Research

Abstract

Background: The 15q11.2 BP1–BP2 microdeletion (Burnside–Butler susceptibility locus) is an emerging condition with over 200 individuals reported in the literature. TUBGCP5, CFYIP1, NIPA1 and NIPA2 genes are located in this chromosome 15 region and when disturbed individually are known to cause neurological, cognitive or behavioural problems as well as playing a role in both Prader–Willi and Angelman syndromes. These syndromes were the first examples in humans of genomic imprinting and typically caused by a deletion but involving the distal chromosome 15q11–q13 breakpoint BP3 and proximally placed breakpoints BP1 or BP2 of different parental origin. The typical 15q11–q13 deletion involves BP1 and BP3 and the typical type II deletion at BP2 and BP3. Several studies have shown that individuals with the larger type I deletion found in both Prader–Willi and Angelman syndromes are reported with more severe neurodevelopmental symptoms compared to those individuals with the smaller type II deletion. Methods: The literature was reviewed and clinical and cytogenetic findings summarised in 200 individuals with this microdeletion along with the role of deleted genes in diagnosis, medical care and counseling of those affected and their family members. Results: Reported findings in this condition include developmental delays (73% of cases) and language impairment (67%) followed by motor delay (42%), attention deficit disorder/attention deficit hyperactivity disorder (35%) and autism spectrum disorder (27%). The de novo deletion frequency has been estimated at 5 to 22% with low penetrance possibly related to subclinical manifestation or incomplete clinical information on family members. A prevalence of 0.6 to 1.3% has been identified in one study for patients with neurological or behavioural problems presenting for genetic services and chromosomal microarray analysis. Conclusions: The summarised results indicate that chromosome 15q11.2 BP1–BP2 microdeletion is emerging as one of the most common cytogenetic abnormalities seen in individuals with intellectual impairment, autism spectrum disorder and other related behavioural or clinical findings, but more research is needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jir.12382

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Deletion of 15q11.2(BP1-BP2) leads to a two- to fourfold increase in the risk for schizophrenia, autism and intellectual disability.

    “Deletion of 15q11.2(BP1–BP2) leads to a two to fourfold increase in the risk for schizophrenia, autism and intellectual disability [1–5].”

    From Linking haploinsufficiency of the autism- and schizophrenia-associated gene Cyfip1 with striatal-limbic-cortical network dysfunction and cognitive inflexibility (2024) · cites this paper as [4]

    The Introduction (Clinical Description; page not provided) estimates a two- to fourfold higher prevalence of the deletion compared with controls, and the Results and Discussion (Genetic Services and Genetic Counseling; page not provided) lists schizophrenia, autism and intellectual disability among findings in affected individuals. It does not give a two- to fourfold risk increase for each of those three conditions; it also describes low penetrance, so “leads to” overstates the relationship. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Butler MG Lee PDK Whitman BY 2006 Management of Prader-Willi Syndrome New York Springer-Verlag
  2. Hagerman RJ Hagerman PJ 2002 Fragile X syndrome: Diagnosis, treatment and research 3 The John Hopkins University Press Baltimore, MD, USA
  3. Rainier S Chai JH Tokarz D Nicholls RD Fink JK 2012 NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6) American Journal of Human Genetics 73 967 971 PMC1180617 14508710

Cited by

Sorted by citations

Authors
Butler, M. G.
Affiliations
University of Kansas Medical Center (US)
Corresponding author
Butler, M. G.
Venue
Journal of Intellectual Disability Research
Publisher
Wiley
Published
2017-04-07
Volume
61
Issue
6
Pages
568-579
ISSN
  • 0964-2633 (ISSN-L)
  • 1365-2788
OpenAlex
W2604781880
Cited by
102
References
51
Citations by year
2026: 5 · 2025: 4 · 2024: 13 · 2023: 12 · 2022: 13 · 2021: 12 · 2020: 18 · 2019: 11 · 2018: 9 · 2017: 3
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • Journal of Intellectual Disability Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Child Health and Human Development (HD02528)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
chromosome 15q11-q13 deletion, Prader-Willi syndrome, Angelman syndrome, genomic imprinting, NIPA1, developmental delay, language impairment, autism spectrum disorder, attention deficit hyperactivity disorder, de novo deletion, intellectual disability, genetic counseling, prevalence
MeSH terms
Chromosome Aberrations, Chromosomes, Human, Pair 15, Humans, Intellectual Disability, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review